Leerink Partners Initiates Coverage On DexCom with Outperform Rating, Announces Price Target of $110
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Mike Kratky has initiated coverage on DexCom (NASDAQ:DXCM) with an Outperform rating and a price target of $110.
October 16, 2023 | 3:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
DexCom has received an Outperform rating from Leerink Partners, with a price target set at $110.
The Outperform rating from Leerink Partners indicates a positive outlook for DexCom. The price target of $110 suggests that the analyst believes the stock has significant upside potential. This could lead to increased investor interest and a potential rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100